Skip to main content
British Journal of Preventive & Social Medicine logoLink to British Journal of Preventive & Social Medicine
. 1975 Dec;29(4):258–261. doi: 10.1136/jech.29.4.258

Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.

D S Freestone, G M Reynolds, J A McKinnon, J Prydie
PMCID: PMC478923  PMID: 766879

Abstract

A total of 1525 schoolgirls aged 13 years from 21 schools in the County Borough of Dudley, were bled for titration of rubella haemagglutinating inhibiting antibody and then were immediately vaccinated with either Wistar RA 27/3 or Cendehill strain live attenuated. Both vaccines were administered subcutaneously by syringe and needle but the Wistar RA 27/3 vaccine was also given by multiple injection apparatus. Significnatly higher conversion rates and geometric mean haemagglutinating inhibiting antibody titres were obtained in girls initially seronegative given the Wister RA 27/3 than in those given the Cendehill vaccine, regardless of the method of vaccination. The RA 27/3 strain was associated with a small but significantly greater incidence of local pain immediately on injection. With this exception, differences in the occurrence of reactions were not found between vaccines, between those initially susceptible and immune or with the level of antibody response.

Full text

PDF
258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Freestone D. S. Programmes for the prevention of rubella during pregnancy by active immunization. Br J Prev Soc Med. 1974 Nov;28(4):258–264. doi: 10.1136/jech.28.4.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Horstmann D. M. Rubella: the challenge of its control. J Infect Dis. 1971 Jun;123(6):640–654. doi: 10.1093/infdis/123.6.640. [DOI] [PubMed] [Google Scholar]
  3. Huygelen C., Peetermans J. Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals. Arch Gesamte Virusforsch. 1967;21(3):357–365. doi: 10.1007/BF01241736. [DOI] [PubMed] [Google Scholar]
  4. Le Bouvier G. L., Plotkin S. A. Precipitin responses to rubella vaccine RA 27-3. J Infect Dis. 1971 Feb;123(2):220–223. doi: 10.1093/infdis/123.2.220. [DOI] [PubMed] [Google Scholar]
  5. Ogra P. L., Kerr-Grant D., Umana G., Dzierba J., Weintraub D. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N Engl J Med. 1971 Dec 9;285(24):1333–1339. doi: 10.1056/NEJM197112092852401. [DOI] [PubMed] [Google Scholar]
  6. Peetermans J., Huygelen C. Attenuation ob rubella virus by serial passage in primary rabbit kidney cell cultures. I. Growth characteristics in vitro and production of experimental vaccines at different passage levels. Arch Gesamte Virusforsch. 1967;21(2):133–143. doi: 10.1007/BF01241438. [DOI] [PubMed] [Google Scholar]
  7. Plotkin S. A., Cornfeld D., Ingalls T. H. Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus. Am J Dis Child. 1965 Oct;110(4):381–389. doi: 10.1001/archpedi.1965.02090030401007. [DOI] [PubMed] [Google Scholar]
  8. Wallace R. B., Isacson P. Comparative trial of HPV-77, DE-5 and RA 27-3 live-attenuated rubella vaccines. Am J Dis Child. 1972 Oct;124(4):536–538. doi: 10.1001/archpedi.1972.02110160074007. [DOI] [PubMed] [Google Scholar]

Articles from British journal of preventive & social medicine are provided here courtesy of BMJ Publishing Group

RESOURCES